Phase II Trial of Induction Therapy With Docetaxel, Cisplatin and Fluorouracil in Previously Untreated Patients With Locally Advanced Squamous Cell Carcinoma and/or Poorly Differentiated Carcinoma of the Nasal Cavity and/or Paranasal Sinuses
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Docetaxel (Primary) ; Cisplatin; Fluorouracil
- Indications Head and neck cancer
- Focus Therapeutic Use
- 02 May 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
- 14 Aug 2015 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov record.
- 21 Oct 2014 Planned End Date changed from 1 Jun 2016 to NULL.